La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Glory Health Industry Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Glory Health Industry ha un patrimonio netto totale di CN¥13.8B e un debito totale di CN¥22.2B, che porta il suo rapporto debito/patrimonio netto a 160.9%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥56.4B e CN¥42.6B.

Informazioni chiave

160.9%

Rapporto debito/patrimonio netto

CN¥22.17b

Debito

Indice di copertura degli interessi	n/a
Contanti	CN¥152.22m
Patrimonio netto	CN¥13.79b
Totale passività	CN¥42.57b
Totale attività	CN¥56.35b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

Oct 07

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Jun 21

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

May 13

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

Oct 04

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Apr 20

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

Sep 02

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥29.7B ) di 2329 superano le sue passività a breve termine ( CN¥29.7B ).

Passività a lungo termine: Le attività a breve termine di 2329 ( CN¥29.7B ) superano le sue passività a lungo termine ( CN¥12.9B ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 159.7% ) di 2329 è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di 2329 si è ridotto da 161.5% a 160.9% negli ultimi 5 anni.

Copertura del debito: Il debito di 2329 non è ben coperto dal flusso di cassa operativo ( 2.3% ).

Copertura degli interessi: Dati insufficienti per determinare se i pagamenti degli interessi sul debito di 2329 siano ben coperti dall'EBIT.

Glory Health Industry Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Recent updates

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane